Cargando…
Determination of administered activities for the treatment of Graves' disease with iodine-131: Proposition of a simplified dosimetric procedure
This prospective study included 35 patients suffering from Graves' disease (GD) clinically and biologically confirmed by endocrinologists, sent to the nuclear medicine department of CHU de Bab El Oued, Algiers for iodine-131 therapy. CHU de Bab El Oued is a tertiary hospital located in the cent...
Autores principales: | Soli, Idrissa Adamou, Issoufou, Djibrillou Moussa, Rahabi, Skander, Ali, Ada, Adehossi, Eric, Bouyoucef, Salah Eddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488895/ https://www.ncbi.nlm.nih.gov/pubmed/34703389 http://dx.doi.org/10.4103/wjnm.WJNM_47_20 |
Ejemplares similares
-
Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease
por: Jhummon, Navina Priya, et al.
Publicado: (2013) -
Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves’ Disease
por: Manohar, Kuruva, et al.
Publicado: (2013) -
Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
por: Wang, Renfei, et al.
Publicado: (2017) -
Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020) -
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
por: Yondorf, Menachem Z., et al.
Publicado: (2020)